Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Details for Patent: 6,248,726

Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,248,726
Title: Method of peritoneal dialysis using glucose polymer solutions
Abstract:There is described polysaccharides of high molecular weight for use in peritoneal dialysis. The polysaccharides are capable of dialysing human serum for long periods of time without causing damage to the peritoneum and are also capable of preventing loss of polymer from the peritoneum to the serum. There is also described a method of making the polysaccharides and pharmaceutical formulations containing them.
Inventor(s): Alsop; Ranulph Michael (Alderley Edge, GB), Forrester; Raymond Brian (Sandbach, GB), Manning; David John (Congleton, GB)
Assignee: M L Laboratories plc (London, GB)
Application Number:07/954,686
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 6,248,726

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,248,726

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United KingdomBA85/15842Jun 22, 1985

International Family Members for US Patent 6,248,726

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 106410 ⤷  Sign up for a Free Trial
Australia 5881186 ⤷  Sign up for a Free Trial
Australia 594060 ⤷  Sign up for a Free Trial
Germany 3689863 ⤷  Sign up for a Free Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.